RecruitingNCT05865054

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

A Longitudinal Study of Orbital and Cranial Vessel Wall MRI in Giant Cell Arteritis by the Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) Collaborative


Sponsor

University of Pennsylvania

Enrollment

400 participants

Start Date

Jul 29, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Magnetic Resonance Imaging (MRI) for people with giant cell arteritis. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Imaging (MRI)

Combined orbital and cranial vessel wall MRI


Locations(4)

Mayo Building and Gonda Building

Rochester, Minnesota, United States

3400 Civic Center Blvd

Philadelphia, Pennsylvania, United States

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada

University Hospital Wuerzburg

Würzburg, Würzburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05865054


Related Trials